News & Updates
Showing Cardiology articles
Showing

Bisphosphonate, denosumab not linked to acute cardiovascular risk
Use of oral bisphosphonate or denosumab does not appear to increase the risk of cardiovascular events (CVEs), namely acute myocardial infarction, unstable angina, cerebrovascular accident, and transient ischemic attack, in persons with incident fracture, a study has shown.

NOACs proven safe, effective in Asians with AF
Use of nonvitamin K antagonist oral anticoagulants (NOACs) helps prevent thromboembolic events in Asian patients with atrial fibrillation (AF), with fewer bleeding events relative to warfarin therapy, according to the results of a study presented at the recent EHRA 2023.

Pregnancy blues may lead to heart problems postpartum
Women with prenatal depression appears to have an elevated cumulative risk of developing cardiovascular disease (CVD) within 24 months postpartum, with the risk persisting despite the absence of co‐occurring hypertensive disorders of pregnancy, as reported in a study.





